ライフサイエンスコーパス: nonsmoking

1 ere 2.5-fold those of dietary compliance and nonsmoking.

2 al rates of decline in lung function than is nonsmoking.

3 was observed for combinations that included nonsmoking.

4 smoking behavior were defined: 1) sustained nonsmoking, 2) early (years 1-2 of the trial) sustained

5 Participants were 4485 nonsmoking 3-17-year-olds from the National Health and N

6 CLAS was an arterial imaging trial in which nonsmoking 40- to 59-year-old men with previous coronary

7 owering Atherosclerosis Study randomized 162 nonsmoking, 40- to 59-year-old men with previous coronar

8 In multivariable-adjusted models, nonsmoking, a healthy body mass index, exercise, and a h

9 and reconfirmed in 1989, is 60 mg daily for nonsmoking adult males.

10 -American (696 women, 388 men) asymptomatic, nonsmoking adult participants of the third National Heal

11 For approximately 2 weeks, 101 nonsmoking adult volunteers living near industrial swine

12 ontrolled trial of erythromycin in currently nonsmoking, adult patients with non-CF bronchiectasis wi

13 nd airway inflammation, we placed 31 healthy nonsmoking adults (18 to 35 yr old) on a diet low in asc

14 dinal study, a representative sample of 5560 nonsmoking adults (mean [SD] age, 49.8 [15.4] years; 45.

15 redictors of secondhand smoke exposure among nonsmoking adults to determine whether exposure changed

16 In a prospective cohort study of 451 nonsmoking adults with asthma, we evaluated the impact o

17 A higher UIC in nonsmoking adults with RP was significantly associated w

18 ed cohorts of mostly middle-aged, White, and nonsmoking adults with specialist-diagnosed pulmonary sa

19 enhancing mucociliary clearance in healthy, nonsmoking adults.

20 Survival among nonsmoking African Americans at 16 years equaled surviva

21 Children of nonsmoking African-American and Dominican women in New Y

22 We selected a matched cohort of 18 lifetime nonsmoking and 27 smoking patients diagnosed with primar

23 In patients with inflammatory disease, nonsmoking and concurrent immunosuppressive use are asso

24 and gallbladder/bile duct cancers) in 69,310 nonsmoking and non-alcohol-drinking women.

25 Efforts to identify risk factors in nonsmoking and nondrinking head and neck squamous cell c

26 es 542 (302 nonexposed, 240 benzene-exposed) nonsmoking and nondrinking mothers of singleton live bir

27 es not fully explain the association between nonsmoking and primary sclerosing cholangitis.

28 ed as FEV1) in comparison with the effect of nonsmoking and regular tobacco smoking.

29 MBF at rest was similar between the nonsmoking and smoking groups (0.97 mL/g/min +/- 0.4 vs

30 23 frequency-matched controls including both nonsmoking and smoking women was conducted in Missouri.

31 participants were drug and medication free, nonsmoking, and otherwise healthy.

32 of overweight or obesity, a healthful diet, nonsmoking, and physical activity, total cholesterol, bl

33 onrural], current smoking status [smoking or nonsmoking], and absence or presence of a previously dia

34 -associated activation of RAS signaling, and nonsmoking-associated activation of EGFR signaling; the

35 Thirty-two nonsmoking asthmatics with HDM allergy were treated with

36 Forty-eight nonsmoking, asymptomatic patients with heterozygous fami

37 Point prevalence for nonsmoking at the interviews was somewhat greater for th

38 One hundred five nonasthmatic and asthmatic nonsmoking bar workers were initially enrolled, of whom

39 simultaneous presence of 4 health behaviors (nonsmoking, body mass index <25 kg/m(2), physical activi

40 5 examination visits between 1987 and 2013: nonsmoking, body mass index <25 kg/m(2), untreated total

41 ted dilatation and cIMT were measured in 213 nonsmoking British civil servants recruited from a prosp

42 cancer overall as a result of NSAID use and nonsmoking, but risk of MSI-H colorectal cancer remains

43 to 1977-1992 mortality in a cohort of 6,338 nonsmoking California Seventh-day Adventists.

44 Offspring of nonsmoking cases comprised another lung cancer high risk

45 susceptibility to lung cancer in families of nonsmoking cases may be evident only in a subset of rela

46 Among nonsmoking cases, there was a significantly higher propo

47 only in a subset of relatives of early-onset nonsmoking cases.

48 nual biometric screening, influenza vaccine, nonsmoking certification, second opinion for elective su

49 88-1994), the authors selected 1,462 healthy nonsmoking children (623 White and 839 African-American)

50 duce the likelihood of smoking initiation in nonsmoking children and adolescents.

51 to -0.000] muV2; P = .04) compared with the nonsmoking cluster.

52 n a group of nicotine-deprived smokers and a nonsmoking comparison group.

53 15 recovered) and 23 age- and gender-matched nonsmoking comparison subjects.

54 10, 0.67 +/- 0.09 ppb, p < 0.01) and with 14 nonsmoking control (8 men, age 33 +/- 2.8 yr) subjects (

55 movie scenes of smoking was contrasted with nonsmoking control scenes that were matched for frequenc

56 Smoking women (n = 8) and nonsmoking control subjects (n = 15) provided 24-h urine

57 ing in LFs in lung explants or biopsies from nonsmoking control subjects (NSC), smokers without COPD

58 endent vasodilation was less in smokers than nonsmoking control subjects during placebo treatment, 8.

59 numbers of T cells producing cytokines from nonsmoking control subjects to smoking control subjects

60 o smoked > or =20 cigarettes per day) and 20 nonsmoking control subjects underwent 2 fluorine 18-fluo

61 th usual COPD and those of 17 smoking and 11 nonsmoking control subjects with normal lung function.

62 lected from patients with COPD, smokers, and nonsmoking control subjects, or of human monocytic U937

63 y higher in nonsmoking T2DM patients than in nonsmoking control subjects.

64 ith mild/moderate asthma (MMAs), and healthy nonsmoking control subjects.

65 an, heavy smokers had greater increases than nonsmoking controls in relative glucose metabolism in th

66 pital with acute exacerbation and 18 healthy nonsmoking controls matched for age.

67 en 1984 and 1987, their 2,252 relatives, 277 nonsmoking controls, and their 2,408 relatives.

68 y disease (COPD), compared with lungs of the nonsmoking controls, linking it mechanistically to CS-in

69 6+/-5% versus 6+/-2%; P=0.002) compared with nonsmoking controls.

70 etry, 16% were smoking controls, and 8% were nonsmoking controls.

71 articipants with >=20 pack-years smoking and nonsmoking controls.

72 Nonsmoking COPD is understudied yet represents some 25%-

73 ical differences between smoking-related and nonsmoking COPD or by smoking-associated methodological

74 5% confidence interval: 0.75, 1.75) than her nonsmoking counterpart.

75 5% confidence interval: 0.44, 1.25) than his nonsmoking counterpart; the average female smoker is pre

76 of patients with COPD or matched smoking and nonsmoking counterparts with normal lung function, we re

77 e have more extensive destruction than their nonsmoking counterparts.

78 h mouse and human smoking groups compared to nonsmoking counterparts.

79 quitting." Prerandomization smoking cues vs nonsmoking cues activated the ventral striatum and media

80 ine residues are significantly higher in the nonsmoking diabetic patients (n = 12) than in normal non

81 ortality than recipients of lungs from adult nonsmoking donors but did not exhibit decreased posttran

82 The nonsmoking donors were subgrouped by age (<20 years or >

83 graft acceptance with comparable outcomes to nonsmoking donors.

84 ility from smoking donors were compared with nonsmoking donors.

85 We observed that as compared to nonsmoking during pregnancy, quitting smoking in the fir

86 estion, 482 young, lean, healthy, sedentary, nonsmoking Eastern Asians (n = 49), Asian-Indians (n = 5

87 as proximal smoking (eg, lit cigarette) and nonsmoking (eg, pencil) cues.

88 onal smoking environments; PSEs) or personal nonsmoking environment (PNEs).

89 ile viewing PSEs, PNEs, standard smoking and nonsmoking environments, as well as proximal smoking (eg

90 atterns, an exposure assessment study of 163 nonsmoking female heads of households enrolled from 30 v

91 quent pregnancy losses in 388 newly married, nonsmoking, female textile workers in China between 1996

92 n a prospective cohort of 526 newly married, nonsmoking, female textile workers in China between 1996

93 tioxidant, and its precursor gamma-GluCys in nonsmoking females exposed to indoor-combustion products

94 ncreasing in incidence, especially in young, nonsmoking females.

95 and 77.9% met hemoglobin A1c, BP, lipid, and nonsmoking goals, respectively; 22.1% met combined ABC t

96 ] cholesterol <2.6 mmol/L [<100 mg/dL]), and nonsmoking goals, respectively; 26.7% met combined ABC (

97 viduals for a well characterized nonclinical nonsmoking group of 97 men (22-80 years).

98 er in the smoking group as compared with the nonsmoking group.

99 Mice were randomly organized into smoking or nonsmoking groups, and the smoking group received cigare

100 Forty-four nonsmoking healthy volunteers (mean age +/- SD, 40 +/- 1

101 Ten nonsmoking healthy volunteers were exposed for 2 h at re

102 Experimental subjects were 16 nonsmoking, healthy young volunteers (ages, 18-25 years)

103 t, lung volume, Hispanic race/ethnicity, and nonsmoking history.

104 antially increased among smoking compared to nonsmoking HIV patients (MRR, 4.4 [95% confidence interv

105 ring winter and summer 2010 in a total of 74 nonsmoking homes in Edmonton, Canada.

106 higher in houses than in apartments for all nonsmoking homes, while only 4 were lower in houses than

107 OCs were higher in smoking homes compared to nonsmoking homes, while the rest had similar levels.

108 p for trend = 0.003) compared with those in nonsmoking households.

109 BP688 PET scans were performed in 10 healthy nonsmoking human volunteers (34 +/- 13 years old); the t

110 Thirty-five healthy, nonsmoking human volunteers 70 years or older were enrol

111 o-random sequence of smoking images, neutral nonsmoking images, and rare targets (photographs of anim

112 gh school graduation rate (+0.028 units) and nonsmoking in adolescents (+0.022 units), amounting to 8

113 status, nonobesity in high school students, nonsmoking in adolescents aged 12 to 17 years, non-marij

114 a tumor cell, is lower in lung cancer among nonsmoking individuals (0-3 mutations/megabase [Mb] vs 0

115 We recruited 52 healthy, nonsmoking individuals (aged 26-83 years) who were eithe

116 Lung cancer in nonsmoking individuals (defined as people who have smoke

117 Lung cancer in nonsmoking individuals accounts for 15% to 20% of lung c

118 Most lung cancers in nonsmoking individuals are histologically adenocarcinoma

119 Among patients with lung cancer, nonsmoking individuals are more likely to have genomic a

120 age Ib to IIIa lung cancer tumor tissue from nonsmoking individuals because actionable genomic altera

121 arrangements, are more common in tumors from nonsmoking individuals compared with those with a smokin

122 5% in never-smokers without asthma; 10.1% in nonsmoking individuals diagnosed with asthma; and 11.1%

123 with smoking and with HIV among current and nonsmoking individuals from a population-based, nationwi

124 e US, the annual incidence of lung cancer in nonsmoking individuals is 14.4 to 20.8 per 100 000 perso

125 Median survival among nonsmoking individuals with advanced non-small cell lung

126 We speculate that nasal inflammation in nonsmoking individuals with asthma increases the conditi

127 ar to individuals with a history of smoking, nonsmoking individuals with lung cancer may present with

128 with low-dose computed tomographic scans for nonsmoking individuals, although screening guidelines va

129 Of itself, except in rare instances in nonsmoking individuals, the PI*SZ phenotype may confer l

130 In patients with fistulous Crohn's disease, nonsmoking is associated with longer duration of respons

131 who smoke are not clinically different from nonsmoking LJ subjects.

132 lected through telephone interviews with 257 nonsmoking lung cancer cases 40-84 years of age diagnose

133 cataract in nondiabetic, nonvegetarian, and nonsmoking male (n = 29,025) and female runners (n = 11,

134 PM(2.5) were investigated in young, healthy, nonsmoking, male North Carolina Highway Patrol troopers.

135 All were nonsmoking, medication- and drug-free, and had no other

136 Nonsmoking men (n = 142) and women (n = 225) aged 45-70

137 er trial was conducted in 19 young, healthy, nonsmoking men and women assigned to consume 24 g whole

138 tary allowance (RDA) for vitamin C for adult nonsmoking men and women is 60 mg/d, which is based on a

139 optimum reduction of chronic disease risk in nonsmoking men and women.

140 Thirty-six nonsmoking men were randomly assigned to receive 6 wk of

141 O A activity was measured in vivo in healthy nonsmoking men with positron emission tomography using a

142 In this population of nonsmoking men with previous bypass surgery, both the co

143 onducted from February 2014 to June 2014, 11 nonsmoking minors aged 14 to 17 years made supervised e-

144 itish Whitehall II cohort, healthy behaviors-nonsmoking, moderate alcohol consumption, >=2.5 hours pe

145 king mother (n = 27) than in children with a nonsmoking mother (23.4 vs 12.5 ppb, P = .006).

146 mean adjusted birth weight among infants of nonsmoking mothers age 30 years or older was 90 g less a

147 Children of passively exposed nonsmoking mothers also had an increased risk (OR = 1.14

148 The inverse association remained only for nonsmoking mothers who drank four or more cups of coffee

149 ociated with clefting among the offspring of nonsmoking mothers, and passive smoke exposures were ass

150 These results suggest that among nonsmoking mothers, high coffee consumption is more like

151 Compared with nonsmoking mothers, maternal first trimester smoking onl

152 Among nonsmoking mothers, paternal smoking was associated with

153 priate birth weight for gestation) of white, nonsmoking mothers.

154 sociation was found among infants of younger nonsmoking mothers.

155 rths with 22-42 completed weeks gestation to nonsmoking mothers.

156 icipants consisted of 218 apparently healthy nonsmoking, nonalcoholic men aged 33-73 years.

157 ion that was 32-fold increased compared with nonsmoking noncarriers.

158 online risk estimator, a 45-year-old obese, nonsmoking, nondiabetic man with total cholesterol of 20

159 restricted to whites, the insured, nonobese, nonsmoking nondrinkers, and specific income categories a

160 We describe 2 nonsmoking, nondrinking couples who developed human papi

161 ent volunteers (18-56 years of age, healthy, nonsmoking, nonhypertensive, not pregnant, with normal p

162 a high rate of limb salvage is practical for nonsmoking, nonuremic diabetic patients.

163 olated from the whole blood of self-reported nonsmoking, nonvaping healthy volunteers.

164 iated with greater declines in FEV1 than was nonsmoking, nor was an additive effect of marijuana and

165 rom nine allergic asthmatic patients and six nonsmoking normal individuals.

166 .6 to 1.7 micron diameter, was inhaled by 10 nonsmoking, normal volunteers each for 45 min.

167 additional 4.1 ischemic strokes per 100,000 nonsmoking, normotensive women using low-estrogen OCs, o

168 We treated nonsmoking (NS) and cigarette smoke (CS)-exposed mice in

169 We collected data prospectively in stable nonsmoking outpatients with cirrhosis.

170 In the good-prognosis subset of nonsmoking p16+ patients with early-stage disease, these

171 f carotid plaque compared with children with nonsmoking parents (relative risk, 1.6; 95% confidence i

172 fied into 3 exposure groups: 1) no exposure (nonsmoking parents, cotinine <1.0 ng/mL); 2) hygienic pa

173 Included were 255 nonsmoking participants (125 African Americans, 130 non-

174 The analysis included 4,557 nonsmoking participants aged 25-55 years.

175 developed from 7,429 asymptomatic, lifelong nonsmoking participants in the third National Health and

176 a movie, allowed us to keep both smoking and nonsmoking participants naive to the goals of the experi

177 At completion of nicotine patch therapy, nonsmoking participants were eligible to be assigned to

178 Nonsmoking participants who lived with a smoker were mor

179 We collected nasal brush samples from 82 nonsmoking participants, including healthy controls and

180 nce before testing and were compared with 37 nonsmoking participants.

181 acid bank of 10,020 individuals, nondiabetic nonsmoking patients (n = 4,811) with angiographically de

182 a cross-sectional observational study of 212 nonsmoking patients aged 18 to 69 years referred to our

183 MATERIAL/METHODS: 140 nonsmoking patients between the ages of 26 and 72 (92 wo

184 age fluid was collected from 23 steroid-free nonsmoking patients with asthma and 10 healthy control s

185 h SA, smokers/ex-smokers with severe asthma, nonsmoking patients with mild/moderate asthma (MMAs), an

186 tients with severe asthma (SA) compared with nonsmoking patients with mild/moderate asthma.

187 Induced sputum was obtained from nonsmoking patients with SA, smokers/ex-smokers with sev

188 In a randomized double-blind design, 40 nonsmoking patients with schizophrenia who had P50 ratio

189 o genes probes were upregulated (>2-fold) in nonsmoking patients with severe asthma compared with MMA

190 The risk of bleeding was greater in nonsmoking patients, and was associated with treatment w

191 of smoking patients than it does in those of nonsmoking patients.

192 t P2Y12 receptor antagonists more than their nonsmoking peers.

193 mokers tend to drink more alcohol than their nonsmoking peers.

194 essure, low-density lipoprotein cholesterol, nonsmoking, physical activity, diet adherence, body mass

195 r (DL(CO)) in a young, healthy population of nonsmoking physicians and medical students aged 22-33 yr

196 n of all age groups in the Northern European nonsmoking population, with slightly higher prevalence f

197 solid lung nodules in the Northern European nonsmoking population.

198 on of solid lung nodules by age and sex in a nonsmoking population.

199 Asian nonsmoking populations have a higher incidence of lung c

200 e and death from IHD was observed only among nonsmoking populations or populations with low prevalenc

201 Thirty-seven healthy, nonsmoking postmenopausal women aged 50-70 y were random

202 Antenatal Asthma Reduction Trial) recruited nonsmoking pregnant women and followed the mother-child

203 Nonsmoking, premenopausal women (n = 12) with confirmed

204 Non-small cell lung cancers driven by nonsmoking-related oncogenes do not harbor genomic scars

205 curring in nonsmokers, alterations in these "nonsmoking-related oncogenes" (NSRO) also occur in smoke

206 ed risks for oral cancer and in the risk for nonsmoking-related oral cancer as well.

207 ed by extinction training (the R-E group) or nonsmoking-related retrieval followed by extinction trai

208 biomarkers collected from 53 healthy, adult, nonsmoking residents of the Iztapalapa and Iztacalco mun

209 We studied 707 nonsmoking retired men, 61 to 81 years of age, who were

210 However, neural responses to smoking and nonsmoking rewards are rarely evaluated within the same

211 nces from participants without asthma in the nonsmoking severe asthma and mild/moderate asthma subgro

212 n intake, higher body mass index, older age, nonsmoking, Spanish speaking, and Hispanic/Latino backgr

213 in which one twin had never smoked and had a nonsmoking spouse, and the other had a smoking history o

214 nd five of 12 females [41.7%]; P = .08), and nonsmoking status (P = .037).

215 ) had the lowest overall attainment, whereas nonsmoking status had the highest (89%).

216 lusion criteria included age 18 to 55 years, nonsmoking status, and negative test results for the pre

217 ociated with decreased creatinine clearance, nonsmoking status, anemia, and greater comorbidity (P(tr

218 ustment for age and sex, an ideal CVH score (nonsmoking status, ideal body mass index, regular physic

219 ter time to fibrinolysis, non-US enrollment, nonsmoking status, prior MI or angina, female sex, anter

220 tor or angiotensin receptor blocker use, and nonsmoking status-was evaluated among 13 616 patients fr

221 150 mg/dl; 4) fasting glucose <126 mg/dl; 5) nonsmoking status; 6) body mass index <25 kg/m(2); and 7

222 <120 mm Hg systolic and 80 mm Hg diastolic; nonsmoking status; and nondiabetic status) had substanti

223 t; regular exercise; normal body mass index; nonsmoking status; and the absence of dyslipidemia, diab

224 ng diabetic patients (n = 12) than in normal nonsmoking subjects (n = 11).

225 ments of BPDE-HSA in plasma from smoking and nonsmoking subjects (range 0.280-2.88 ng BPDE-HSA/mg HSA

226 The analysis was carried out in 132 nonsmoking subjects aged 37-73 years who were randomly s

227 ine oxidase B (MAO-B) levels than comparison nonsmoking subjects and to determine if levels recover a

228 n, the alveolar phase breath gas of healthy, nonsmoking subjects was sampled on NTDs.

229 The participants were 23 medication-free, nonsmoking subjects with familial, early-onset depressio

230 Smoking and nonsmoking subjects with schizophrenia (n=31) and age-,

231 for the treatment of cognitive impairment in nonsmoking subjects with schizophrenia.

232 onstrate a consistent effect on cognition in nonsmoking subjects with schizophrenia; however, a trend

233 Seven healthy nonsmoking subjects with type 2 diabetes were studied be

234 When we evaluated the subgroup of nonsmoking subjects, budesonide caused a significant red

235 A total of 49 young (age 20 to 35 years) nonsmoking subjects, comprising elite rowers and age- an

236 BT-126 demonstrated a procognitive effect in nonsmoking subjects, particularly in verbal learning, wo

237 In 15 healthy male nonsmoking subjects, the response of choroidal perfusion

238 neuroplasticity and cortical excitability in nonsmoking subjects.

239 rved when cigarette smokers were compared to nonsmoking subjects.

240 Optimal CVD risk was defined as nondiabetic, nonsmoking, systolic blood pressure (SBP) < 120 and dias

241 cts were found to be significantly higher in nonsmoking T2DM patients than in nonsmoking control subj

242 eclampsia (for heavy smoking, light smoking, nonsmoking, test for trend p = 0.002 for underweight and

243 aining peptide to evaluate protein damage in nonsmoking type 2 diabetes mellitus.

244 rrent recommendations) and 4 health factors (nonsmoking, untreated total cholesterol <200 mg/dL, untr

245 A total of 33 healthy, nonsmoking, volunteer subjects (23 men, ten women).

246 d through the bronchoscope into the lungs of nonsmoking volunteers.

247 months before/during pregnancy compared with nonsmoking was 1.15 (95% confidence interval (CI): 1.04,

248 body mass index, ideal glucose control, and nonsmoking was associated with less likelihood of advers

249 For CV health behaviors, nonsmoking was most prevalent (range, 60.2%-90.4%), wher

250 DNAm by smoking (current vs. nonsmoking) was tested within each ancestry group using

251 rs2472299G>A, female sex, and nonsmoking were significantly inversely related to coffe

252 (continuous smoking, quit-early smoking, and nonsmoking) were previously obtained.

253 w birth weight for gestation infants born to nonsmoking white mothers and that this is independent of

254 Americans at 16 years equaled survival among nonsmoking whites.

255 R patients had a similar clinical profile: a nonsmoking woman with severe, persistent perennial rhini

256 ry flow (PEF) was studied in a sample of 473 nonsmoking women (age 19 to 43 yr) in Virginia over summ

257 Results were similar in nonsmoking women aged <35 years with normal weight and n

258 use of the Eating Inventory in 638 healthy, nonsmoking women aged 55-65 y.

259 e of programs aimed at smoking prevention in nonsmoking women and smoking cessation in smoking women

260 tal Growth Studies-Singletons, enrolled 2055 nonsmoking women at low risk for fetal growth abnormalit

261 Coffee intake was lowest in nonsmoking women homozygous for rs2472299G>A (3.49 cups/

262 In a longitudinal cohort study of nonsmoking women in New York City, we measured PAH expos

263 iratory symptoms and lung function in young, nonsmoking women in rural Guatemala, using measured carb

264 Among 2,162 nonsmoking women recruited from three Boston, Massachuse

265 A birth cohort study that included 10,095 nonsmoking women who delivered a singleton live birth wa

266 atient cases and 364 controls, compared with nonsmoking women who did not receive PMRT, nonsmoking wo

267 h nonsmoking women who did not receive PMRT, nonsmoking women who received PMRT had no higher risk of

268 Among nonsmoking women, current household SHS exposure was ass

269 d consumption may reduce lung cancer risk in nonsmoking women, particularly for aggressive tumors, an

270 factors in the etiology of lung cancer among nonsmoking women.

271 , and 21 percent of deaths from cancer among nonsmoking women.

272 ntiated tumors and 11 (55%) of which were in nonsmoking women.

273 home or work increases the risk of CHD among nonsmoking women.

274 n soy food intake and lung cancer risk among nonsmoking women.

275 om 2001 to 2010, the overall SHS exposure in nonsmoking workers declined with substantial drops in fo

276 emporal trends of secondhand smoke exposure: nonsmoking workers in the United States (NHANES 2001-201

277 luated temporal trends in SHS exposure among nonsmoking workers in the United States and identified t

278 evels had changed -25% (95% CI: -39, -7%) in nonsmoking workers.

279 s34 locus of human serum albumin (HSA) in 29 nonsmoking Xuanwei and Fuyuan females who used smoky coa

280 Blood was collected from healthy, nonsmoking, young adults during 3 study periods that inc